EBS Financial Facts

Total revenues: 98.11M
Contracts and grants: 12.44M
See Full Income Statement

Long-term indebtedness, net of current portion: 62M
Total current assets: -446.14M
See Full Balance Sheet

Emergent BioSolutions, Inc. (EBS) Earnings

  |   Expand Research on EBS
Next EPS Date 5/5/14 *Est. EPS Growth Rate -4.5% *Last Qtr.
Average EPS % Beat Rate +22.0% Revenue Growth Rate -0.5% *Last Qtr.
Average % Move 1-Wk after EPS +4.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/8/12 Q411 $0.78$0.72 +$0.06$107.95M$109.32M = +73.7% Details
3/10/11 Q410 $0.78$0.67 +$0.11$103.2M$102.03M = +13.1% Details
3/7/13 Q412 $0.44$0.45 -$0.01$94.6M$95.09M = +67.4% Details
3/6/14 Q413 $0.42$0.36 +$0.06$94.1M$93.83M = -1.1% Details
8/4/11 Q211 $0.40$0.34 +$0.06$88.1M$84.2M = +39.7% Details
11/7/13 Q313 $0.37$0.21 +$0.16$89.1M$79.13M = +38% Details
8/2/12 Q212 $0.21$0.23 -$0.02$70.4M$76.2M = +77.3% Details
8/5/13 Q213 $0.29$0.21 +$0.08$82.4M$75.73M = +41.6% Details